Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 317

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Chemotherapy Use among Medicare Beneficiaries at the End of Life

Emanuel, Ezekiel J., Young-Xu, Yinong, Levinsky, Norman G., Gazelle, Gail, Saynina, Olga, Ash, Arlene S. · 2003 · Annals of Internal Medicine

Abstract

BACKGROUND: Although many observers believe that cancer chemotherapy is overused at the end of life, there are no published data on this. OBJECTIVE: To determine the frequency and duration of chemotherapy use in the last 6 months of life stratified by type of cancer, age, and sex. DESIGN: Retrospective cohort analysis. SETTING: Administrative databases from Massachusetts and California. PATIENTS: All Medicare patients who died of cancer in Massachusetts and 5% of Medicare cancer decedents in California in 1996. MEASUREMENTS: Use of intravenous chemotherapy agents, chemotherapy administration, or medical evaluation for chemotherapy from Medicare billing data for each patient in 30-day periods from the date of death backward. RESULTS: In Massachusetts, 33% of cancer decedents older than 65 years of age received chemotherapy in the last 6 months of life, 23% in the last 3 months, and 9% in the last month. In California, the percentages were 26%, 20%, and 9%, respectively. Chemotherapy use greatly declined with age. Chemotherapy use was similar for patients with breast, colon, and ovarian cancer and those with cancer generally considered unresponsive to chemotherapy, such as pancreatic, hepatocellular, or renal-cell cancer or melanoma. Patients with types of cancer that are unresponsive to chemotherapy had shorter duration of chemotherapy use. CONCLUSION: Among patients who died of cancer, chemotherapy was used frequently in the last 3 months of life. The cancer's responsiveness to chemotherapy does not seem to influence whether dying patients receive chemotherapy at the end of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-138-8-200304150-00011

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 317

Metadata

Authors
Emanuel, E. J., Young-Xu, Y., Levinsky, N. G., Gazelle, G., Saynina, O., & Ash, A. S.
Venue
Annals of Internal Medicine
Published
2003-04-15
Volume
138
Issue
8
Pages
639-643
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2133615628
Cited by
317
References
15
FWCI
10.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy Use among Medicare Beneficiaries at the End of Life. https://app.cochat.ai/papers/10.7326/0003-4819-138-8-200304150-00011
The paper
Emanuel, E. J., Young-Xu, Y., Levinsky, N. G., Gazelle, G., Saynina, O., & Ash, A. S. (2003). Chemotherapy Use among Medicare Beneficiaries at the End of Life. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-138-8-200304150-00011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.